Definitive Contract 75F40119C10097
Award Date
8/28/19
Potential Completion Date
9/15/22
Potential Value
$2.3M
Federal Agency
Food and Drug Administration
Awardee
Kaiser Foundation Hospitals
Ultimate Awardee
Kaiser Foundation Health Plan, Inc.
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Oakland, CA 94612, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
34
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Kaiser Foundation Hospitals, doing business as Kaiser Permanente, was awarded a definitive cost-no-fee contract by the Department of Health and Human Services Food and Drug Administration (FDA) on September 26, 2018. The contract has a potential value of $5,646,115.20 and completion date of February 28, 2023. It concerns research on the effects of medical products on suicidal ideation and behavior through real world evidence, as initially solicited in a February 13, 2018 Broad Agency...
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, has been awarded a firm fixed price purchase order valued at $19,827.67 by the National Institutes of Health's National Institute on Drug Abuse. The contract is for Kaiser Permanente to finalize project objectives and scope for a patient cohort study, including eligibility criteria and intended outcomes. Performance will take place in Baltimore, Maryland over a one year period from...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $25,000 firm fixed price purchase order to Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, to deliver products or services associated with POTS 23-4116 DELIVERABLE 2. As the prime contractor, Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division will perform the work out of its Baltimore,...
This federal contract award to Kaiser Foundation Hospitals, a subsidiary of Kaiser Foundation Health Plan, Inc., was issued by the Food and Drug Administration (FDA) to examine the impact of a benzodiazepine (BZD) care plan and electronic health record BZD prescribing on BZD prescribing, in parallel with provider education. The $1,233,980 definitive, firm-fixed-price contract has a period of performance through September 29, 2026. The contract was awarded pursuant to a Broad Agency...
This is a federal contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract has a ceiling value of $42,304,985.02 and is a definitive contract with a cost-no-fee pricing type. The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. Kaiser Permanente is a large, non-profit healthcare provider and...
This federal contract award, valued at $350,000.00, was issued by the Agency for Healthcare Research and Quality (AHRQ) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a prominent non-profit healthcare provider and research organization. The contract is for "METHODS AND DISSEMINATION: COLLABORATION TO IMPROVE VALIDITY, CONSISTENCY, AND UTILITY OF SYSTEMATIC REVIEWS" and is a delivery order under the Evidence-based Practice Centers VI (EPC VI) indefinite delivery...
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, was awarded a $24,999 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Office of Logistics and Acquisition Operations. To be performed in Rockville, Maryland through August 2024, this contract has no set-aside designation and is likely to facilitate research support services aligned with Kaiser Permanente's capabilities and...
This federal contract award is for $636,976.25 and was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a nonprofit healthcare provider and research organization. The contract is for infrastructure setup and is a delivery order under the larger "Cancer Study Cohort Recruitment" indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The...
This is a definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for a prospective observational cohort study to assess the effectiveness of SARS-CoV-2 vaccines. The $55,223,588.00 contract has an ultimate completion date of December 31, 2024 and is a cost-no-fee arrangement. The contract does not have a set-aside designation. Kaiser Permanente is collaborating with the University of...
This $1,986,836.74 firm fixed-price federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract, awarded on July 1, 2021, supports FY 2021 Broad Agency Announcement (BAA) Topic 9 - KPSC, with a period of performance ending on September 30, 2022. This contract is not set aside for any small business categories. Kaiser Permanente...